Product Image

Boswellia Extract 500 mg

California Gold Nutrition
4.7
★ ★ ★ ★ ★
(9998 ratings)
Boswellia 500 mg
Turmeric 200 mg
Product Image
Score84
Substantial branded boswellia and meaningful turmeric provide strong value. Missing active-acid percentages and absorption support are the main limitations.
How scoring works
Quantity:120 Capsule(s) • (60 servings)
Goals:
Anti-Inflammatory Support
Joint Health

Score 84

Substantial branded boswellia and meaningful turmeric provide strong value. Missing active-acid percentages and absorption support are the main limitations.
How scoring works
$12.76($0.21 per serving)
Amazon
$ 17.02
iHerb
$ 12.76
Report prices

Analysis

Two capsules provide 500 mg Boswellin boswellia extract plus 200 mg turmeric extract and 200 mg turmeric powder. Boswellia reaches a commonly useful extract amount, while the turmeric extract likely supplies a meaningful curcuminoid dose.

The branded boswellia source improves quality confidence over an unnamed extract. Active boswellic-acid and AKBA yields are still missing, and neither black pepper nor lipid delivery is listed.

Sixty servings and low daily cost make the formula one of the better-value combinations supplied. It fits users seeking substantial boswellia with supporting turmeric rather than an optimized curcumin-only product.

Who is it for
  • Adults seeking boswellia-curcumin capsules
  • Users who value clearly listed botanical weights
  • People who can screen herb-specific medication and tolerance concerns
Best for
  • Comparing botanical form and dose
  • Goal-aligned supplement selection
  • Users who prefer boswellia-curcumin capsules

Pros

  • Provides 500 mg branded Boswellin extract
  • Includes turmeric extract and powder
  • Sixty servings
  • Low serving cost

Cons

  • No boswellic-acid percentage
  • No AKBA amount
  • No dedicated absorption enhancer
  • Turmeric root powder has unknown active yield

Warnings

  • Turmeric may increase bleeding tendency with anticoagulant or antiplatelet medicines
  • Turmeric can aggravate symptoms in people with gallstones or bile-duct obstruction
  • Stop use if the concentrated botanicals cause persistent nausea, reflux, or abdominal discomfort

Nutrient quality

83 Highest impact

A substantial branded boswellia extract and concentrated turmeric create strong joint-focused coverage. Boswellic-acid and curcuminoid percentages remain partly unclear.

.

Ingredient transparency

84 Highest impact

Individual active weights are clearly disclosed. Some extract percentages, enzyme activity, or non-active label details remain incomplete.

.

Customer satisfaction

78 High impact

The supplied rating and large feedback base indicate consistently favorable satisfaction. No complaint-level evidence was supplied to assess recurring issues or purpose-specific experiences.

.

Value for money

89 Highest impact

The serving cost is favorable for the amount of formula provided. Potency and standardization gaps still reduce certainty about effective value.

.
Report analysis

Goals

Anti-Inflammatory Support
Impact
Highest effect
A Goal FitB+ Strength of SupportA- CoverageA- Formula Quality
Boswellia · 500 mg

Boswellia and turmeric provide direct, complementary support for major inflammatory signaling routes. The Boswellin amount is substantial, and the added turmeric broadens the formula beyond a single pathway.

Missing boswellic acid and curcuminoid percentages make the true active yields uncertain. The dry capsule also lacks an absorption enhancer, so the strong ingredient logic is tempered by incomplete potency and delivery details.

Study evidence
Boswellia Supportive 19 studies
Joint Health
Impact
High effect
A- Goal FitB- Strength of SupportC+ CoverageB+ Formula Quality
Boswellia · 500 mg

Boswellia and turmeric directly target complementary inflammatory pathways involved in joint discomfort. The combination is well aligned with comfort and mobility, although it does not provide cartilage or lubrication ingredients.

The boswellia extract amount is substantial, and the turmeric extract identifies curcuminoids without stating their percentage. Duplicate turmeric entries create some dose ambiguity, while boswellic-acid or AKBA standardization is also absent.

Study evidence
Boswellia Supportive 24 studies

Ingredients

IngredientAmount per serving
Boswellin (Boswellia serrata Gum Resin Extract)
500 mg
Turmeric Root Extract (Curcuminoids)
200 mg
Turmeric, Powder
200 mg
Gluten Free Adults 18–50 Vegan Dairy Free Vegetarian
Report overview
D Active Ingredient Quality & BioavailabilityA- Dose, Safety & Label TransparencyA+ Value

The branded Boswellin extract supports a stronger quality case than an unnamed extract, though its acid percentage is not shown. The 500 mg amount reaches the standard clinical range, while the capsule lacks added absorption technology. Low serving cost makes it a strong value among the listed options.

D+ Active Ingredient Quality & BioavailabilityD Dose, Safety & Label TransparencyB- Value

The standardized extract likely supplies about 190 mg of curcuminoids, while an equal amount of root powder adds unverified turmeric material. No black pepper, lipid base, or advanced delivery system is listed. Boswellia and concentrated curcuminoids may increase bleeding risk for people using warfarin or antiplatelet medicines.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study.
    Kumar B; Ghaytidak AB; Pandey AK; Somepalli RR; Sarda P; Raychaudhuri SP; Rokkam MP · Journal of the American Nutrition Association · 2025
    Randomized trial80 participantsJoint Health Anti-Inflammatory Support forBoswellia
  2. Efficacy of Extracts of Oleogum Resin of Boswellia in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis.
    Dalmonte T; Andreani G; Rudelli C; Isani G · Phytotherapy research : PTR · 2024
    Meta-analysis1,185 participants13 studies pooledJoint Health forBoswellia
  3. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
    Majeed M; Majeed S; Narayanan NK; Nagabhushanam K · Phytotherapy research : PTR · 2019
    Randomized trial48 participantsAnti-Inflammatory Support forBoswellia
  4. Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn's disease: good safety profile but lack of efficacy.
    Holtmeier W; Zeuzem S; Preiss J; Kruis W; Böhm S; Maaser C; Raedler A; Schmidt C; Schnitker J; Schwarz J; Zeitz M; Caspary W · Inflammatory bowel diseases · 2011
    Randomized trial108 participantsAnti-Inflammatory Support forBoswellia
  5. Clinical Benefits of Boswellia Serrata (BOSMAX®) in Early Knee Osteoarthritis: A Randomized, Placebo-Controlled, Double-Blind Study.
    Jayaram M; Kim J; Baek KS; Jung H; Kim J; M K P; T S C; H B S; Ramaiah V; S P · Journal of medicinal food · 2025
    Randomized trial150 participantsAnti-Inflammatory Support forBoswellia
  6. Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
    Karima S; Aghamollaii V; Mahmoodi Baram S; Balenci L; Lanctôt KL; Kiss A; Tafakhori A; Mahdavi M; Rajaei S; Shateri S; Yarhoseini A; Mokhtari F; Fotouhi A; Riazi A · Journal of Alzheimer's disease : JAD · 2023
    Randomized trial85 participantsAnti-Inflammatory Support forBoswellia
  7. A standardized Boswellia serrata extract shows improvements in knee osteoarthritis within five days-a double-blind, randomized, three-arm, parallel-group, multi-center, placebo-controlled trial.
    Majeed A; Majeed S; Satish G; Manjunatha R; Rabbani SN; Patil NVP; Mundkur L · Frontiers in pharmacology · 2024
    Randomized trial105 participantsAnti-Inflammatory Support Joint Health forBoswellia
  8. Oral herbal therapies for treating osteoarthritis.
    Cameron M; Chrubasik S · The Cochrane database of systematic reviews · 2015
    Meta-analysis5,980 participants49 studies pooledJoint Health forBoswellia
  9. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study.
    Haroyan A; Mukuchyan V; Mkrtchyan N; Minasyan N; Gasparyan S; Sargsyan A; Narimanyan M; Hovhannisyan A · BMC complementary and alternative medicine · 2018
    Randomized trial201 participantsJoint Health forBoswellia
  10. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.
    Sengupta K; Alluri KV; Satish AR; Mishra S; Golakoti T; Sarma KV; Dey D; Raychaudhuri SP · Arthritis research & therapy · 2009
    Randomized trial75 participantsJoint Health forBoswellia